Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 706 AL 720

Fatigue in Parkinson's disease: concepts and clinical approach

Nassif DV, Pereira JS.

Psychogeriatrics. 2018 Mar;18(2):143-150. doi: 10.1111/psyg.12302. Epub 2018 Feb 6.

PDGF/PDGFR axis in the neural systems

Sil S, Periyasamy P, Thangaraj A, Chivero ET, Buch S.

Mol Aspects Med. 2018 Aug;62:63-74. doi: 10.1016/j.mam.2018.01.006. Epub 2018 Feb 6.

Release and uptake of pathologic alpha-synuclein

Grozdanov V, Danzer KM.

Cell Tissue Res. 2018 Jul;373(1):175-182. doi: 10.1007/s00441-017-2775-9. Epub 2018 Feb 6.

Understanding Miro GTPases: Implications in the Treatment of Neurodegenerative Disorders

Kay L, Pienaar IS, Cooray R, Black G, Soundararajan M.

Mol Neurobiol. 2018 Sep;55(9):7352-7365. doi: 10.1007/s12035-018-0927-x. Epub 2018 Feb 6.

Beneficial Effects of Flavonoids Against Parkinson's Disease

Jung UJ, Kim SR.

J Med Food. 2018 May;21(5):421-432. doi: 10.1089/jmf.2017.4078. Epub 2018 Feb 7.

MCI in Parkinson's disease

Friedman JH.

Parkinsonism Relat Disord. 2018 Feb;47:1-2. doi: 10.1016/j.parkreldis.2018.01.015.

Motor learning in people with Parkinson's disease: Implications for fall prevention across the disease spectrum

Paul SS, Dibble LE, Peterson DS.

Gait Posture. 2018 Mar;61:311-319. doi: 10.1016/j.gaitpost.2018.01.026. Epub 2018 Jan 31.

Symbol Digit Modalities Test adaptation for Magnetic Resonance Imaging environment: A systematic review and meta-analysis

Silva PHR, Spedo CT, Barreira AA, Leoni RF.

Mult Scler Relat Disord. 2018 Feb;20:136-143. doi: 10.1016/j.msard.2018.01.014. Epub 2018 Jan 31.

Metformin-induced encephalopathy: the role of thiamine

McGarvey C, Franconi C, Prentice D, Bynevelt M.

Intern Med J. 2018 Feb;48(2):194-197. doi: 10.1111/imj.13693.

The launch of opicapone for Parkinson's disease: negatives versus positives

Castro Caldas A, Teodoro T, Ferreira JJ.

Expert Opin Drug Saf. 2018 Mar;17(3):331-337. doi: 10.1080/14740338.2018.1433659.

Is Parkinson's Disease a Neurodevelopmental Disorder and Will Brain Organoids Help Us to Understand It?

Schwamborn JC.

Stem Cells Dev. 2018 Jul 15;27(14):968-975. doi: 10.1089/scd.2017.0289. Epub 2018 Mar 12.

MSA Mimic? Rare Occurrence of Anti-Hu Autonomic Failure and Thymoma in a Patient with Parkinsonism: Case Report and Literature Review

Ricigliano VAG, Fossati B, Saraceno L, Cavalli M, Bazzigaluppi E, Meola G.

Front Neurosci. 2018 Jan 24;12:17. doi: 10.3389/fnins.2018.00017. eCollection 2018.

Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease

Szökő É, Tábi T, Riederer P, Vécsei L, Magyar K.

J Neural Transm (Vienna). 2018 Nov;125(11):1735-1749. doi: 10.1007/s00702-018-1853-9. Epub 2018 Feb 7.

Dopamine receptors: homomeric and heteromeric complexes in L-DOPA-induced dyskinesia

Solís O, Moratalla R.

J Neural Transm (Vienna). 2018 Aug;125(8):1187-1194. doi: 10.1007/s00702-018-1852-x. Epub 2018 Feb 7.

Glycotoxins: Dietary and Metabolic Origins; Possible Amelioration of Neurotoxicity by Carnosine, with Special Reference to Parkinson's Disease

Hipkiss AR.

Neurotox Res. 2018 Jul;34(1):164-172. doi: 10.1007/s12640-018-9867-5. Epub 2018 Feb 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias